(lp0
S'IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action ... Yahoo Finance - Feb 6, 2017 LOS ANGELES, CA / ACCESSWIRE / March 13, 2017 / Lundin Law PC, a shareholder rights firm, announces the filing of a class action lawsuit against Stemline Therapeutics, Inc.   concerning possible violations of federal&nbsp;...'
p1
aS'Stemline Therapeutics Reports Fourth Quarter 2016 Financial Results GlobeNewswire  - Mar 16, 2017 NEW YORK, March 16, 2017  -- Stemline Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics for oncology indications of unmet medical need, announced today financial results&nbsp;...'
p2
aS'Why Stemline Therapeutics Inc Stock Is Climbing Today Motley Fool - Jan 6, 2017 The biotech stock rollercoaster known as Stemline Therapeutics Inc  popped Friday morning with a 21.8% gain, and it was still up about 14.5% as of 11:44 a.m.Stemline Therapeutics  Spikes after announcing FDA Agreement - Economic Calendar'
p3
aS'Stemline Therapeutics Inc  Given Outperform Rating at Wedbush Chaffey Breeze - 10 hours ago Stemline Therapeutics Inc logo Wedbush reiterated their outperform rating on shares of Stemline Therapeutics Inc  in a research note published on Friday morning.Stemline Therapeutics Inc Receives a Buy from HC Wainwright - Analyst RatingsThe Way Analysts See Stemline Therapeutics, Inc.  - Post Analyst'
p4
aS"ALERT: Rosen Law Firm Reminds Stemline Therapeutics, Inc. Investors of ... Yahoo Finance - Mar 13, 2017 NEW YORK, March 13, 2017  -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Stemline Therapeutics, Inc. securities :  pursuant and/or traceable to Stemline's secondary public offering on or about&nbsp;..."
p5
aS'Stemline Therapeutics to Present at the Cowen and Company 37th Annual Health ... GlobeNewswire  - Feb 21, 2017 NEW YORK, March 02, 2017  -- Stemline Therapeutics, Inc. , a clinical-stage biopharmaceutical company developing novel therapeutics for oncology indications of unmet medical need, announced today that Ivan&nbsp;...'
p6
aS"Here's Why Stemline Therapeutics Stock Fell 36.9% This Morning Motley Fool - Feb 2, 2017 Shares of Stemline Therapeutics  tumbled nearly 37% this morning after investors learned that a patient died in a clinical trial involving its lead drug candidate, SL-401.Side Effect Kills Cancer Patient in Stemline Therapeutics Drug Trial; Company ... - TheStreet.com"
p7
aS'Shareholder Deadline Reminder : Johnson &amp; Weaver, LLP Announces ... PR Newswire  - Mar 17, 2017 SAN DIEGO, March 17, 2017 /PRNewswire/ -- Shareholder Rights Law Firm Johnson &amp; Weaver, LLP  announces the filing of a class action lawsuit on behalf of purchasers of Stemline Therapeutics, Inc.  between January 6, 2017 and&nbsp;...'
p8
aS"Newman Ferrara LLP Announces Corporate Governance Investigation of Stemline ... Yahoo Finance - Feb 14, 2017 Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Stemline Therapeutics Inc.   into potential breaches of fiduciary duty by the Company's Board of Directors ...Newman Ferrara LLP Announces Corporate Governance Investigation of Dimension ... - Business Wire "
p9
aS'Stemline Therapeutics,Inc.  Files An 8-K Results of Operations ... Market Exclusive - Mar 17, 2017 Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing oncology therapeutics.Stemline Therapeutics Inc.  Moves Lower on Volume Spike for March 17 - Equities.comHot Stocks Report: Kopin Corporation , Stemline Therapeutics, Inc.  - Post Analyst'
p10
a.